Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC).

被引：0
|
作者：
Luen, Stephen James
Salgado, Roberto
Dieci, Maria Vittoria
Vingiani, Andrea
Curigliano, Giuseppe
Hubbard, Rebekah
Altamirano, Carlos Castaneda
Sanchez, Joselyn
D'Alfonso, Timothy
Cheng, Esther
Garcia, Miluska Castillo
Adams, Sylvia
Ahmed, Fahad
Rimm, David L.
Demaria, Sandra
Symmans, William Fraser
Michiels, Stefan
Loi, Sherene
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Inst Jules Bordet, Brussels, Belgium
[3] Univ Padua, Padua, Italy
[4] Ist Oncol Veneto IRCCS, Padua, Italy
[5] Ist Eur Oncol, Milan, Italy
[6] Univ Milan, Ist Eur Oncol, Milan, Italy
[7] Univ Texas MD Anderson Canc Ctr, Div Pathol, Houston, TX 77030 USA
[8] Inst Nacl Enfermedades Neoplas, Lima, Peru
[9] Cornell Univ, New York, NY 10021 USA
[10] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY USA
[11] Yale Univ, New Haven, CT USA
[12] Yale Sch Med, New Haven, CT USA
[13] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY USA
[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[15] Inst Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
571
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neo-adjuvant Chemotherapy for triple-negative breast cancer: a place for platinum?
    Goncalves, Anthony
    BULLETIN DU CANCER, 2014, 101 (12) : 1063 - 1063
  • [42] CD4/CD8 Ratio of Tumor-Infiltrating Lymphocytes (TIL) at the Tumor-Host Interface (THI) Has Prognostic Value in Triple Negative Breast Cancer (TNBC)
    Wang, Kai
    Shen, Tiansheng
    Siegal, Gene P.
    Wei, Shi
    LABORATORY INVESTIGATION, 2017, 97 : 77A - 78A
  • [43] Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study (vol 25, pg 611, 2015)
    Dieci, M. V.
    Criscitiello, C.
    Goubar, A.
    Viale, G.
    Conte, P.
    Guarneri, V.
    Ficarra, G.
    Mathieu, M. C.
    Delaloge, S.
    Curigliano, G.
    Andre, F.
    ANNALS OF ONCOLOGY, 2015, 26 (07) : 1518 - 1518
  • [44] CD4/CD8 Ratio of Tumor-Infiltrating Lymphocytes (TIL) at the Tumor-Host Interface (THI) Has Prognostic Value in Triple Negative Breast Cancer (TNBC)
    Wang, Kai
    Shen, Tiansheng
    Siegal, Gene P.
    Wei, Shi
    MODERN PATHOLOGY, 2017, 30 : 77A - 78A
  • [45] Tumor-infiltrating lymphocytes to predict survival to anthracycline/taxane-based adjuvant chemotherapy in triple negative breast cancer.
    Ou, Qiyun
    Yu, Yunfang
    Xiao, Xiaoyun
    Luo, Baoming
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [46] Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
    Hall, C.
    Hess, R.
    Ravenberg, L.
    Clayborn, A.
    Rauch, G. M.
    Candelaria, R.
    Mittendorf, E. A.
    Moulder, S. L.
    Thompson, A.
    Lucci, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [47] Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer
    Dulgar, Ozgecan
    Ilvan, Sennur
    Turna, Zeynep Hande
    EUROPEAN JOURNAL OF BREAST HEALTH, 2020, 16 (04) : 276 - 281
  • [48] Subtyping of residual disease (RD) following neoadjuvant chemotherapy (NACT) for triple negative breast cancer (TNBC): Evolution and prognostic impact
    Diaz-Guardamino, I. Echavarria
    Lopez-Tarruella Cobo, S.
    Del Monte-Millan, M.
    Alvarez, E.
    Jerez Gilarranz, Y.
    Moreno Anton, F.
    Garcia Saenz, J. A.
    Massarrah, T.
    Ocana, I.
    Cebollero, M.
    Ballesteros Garcia, A. I.
    Bohn Sarmiento, U.
    Gomez, H.
    Fuentes Rivera, H.
    Herrero Lopez, B.
    Polo, C.
    Bueno, O.
    Rahimi, P.
    Bueno Muino, C.
    Martin Jimenez, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S324 - S325
  • [49] The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
    Ibrahim, Ezzeldin M.
    Al-Foheidi, Meteb E.
    Al-Mansour, Mubarak M.
    Kazkaz, Ghieth A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) : 467 - 476
  • [50] Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
    Geurts, Veerle C. M.
    Balduzzi, Sara
    Steenbruggen, Tessa G.
    Linn, Sabine C.
    Siesling, Sabine
    Badve, Sunil S.
    DeMichele, Angela
    Ignatiadis, Michail
    Leon-Ferre, Roberto A.
    Goetz, Matthew P.
    Wolff, Antonio C.
    Klar, Natalie
    Michiels, Stefan
    Loi, Sherene
    Adams, Sylvia
    Horlings, Hugo M.
    Sonke, Gabe S.
    Salgado, Roberto
    Kok, Marleen
    JAMA ONCOLOGY, 2024,
12345